Key Market Indicators
New Zealand's vaccination coverage for children aged one year is projected to reach 94% by 2028, up from 93% in 2023. This represents an average annual growth of 0.2 percentage points. Remarkably, the country's vaccination rate has seen no significant change since 1988. In the realm of vaccine exports, New Zealand's figures are expected to climb to approximately $8.5 million by 2028, up from $6.8 million in 2023. This marks an average annual growth rate of 3.5%. Since 1994, New Zealand's vaccine supply has increased by 7.9% each year. The country ranked 34th in vaccine exports in 2023, with Slovakia surpassing New Zealand's $6.8 million mark. Leading the global rankings are Belgium, the United Kingdom, and France, occupying the second, third, and fourth spots respectively. On the import side, New Zealand's vaccine imports are forecasted to reach around $50.3 million by 2028, growing from $45.3 million in 2023. This indicates an average annual growth rate of 1.5%. Since 1994, the country's demand for vaccines has seen a modest annual increase of 0.8%.
